Tousoulis / Stefanadis Biomarkers in Cardiovascular Diseases

Erscheinungsjahr 2013
ISBN: 978-1-4665-8715-1
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 450 Seiten

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians.

The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book.

Autoren/Hrsg.

Tousoulis, Dimitris

Stefanadis, Christodoulos

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie

Inhaltsverzeichnis

Part I: Classical biomarkers

C-reactive protein in cardiovascular disease
Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD, Christodoulos Stefanadis MD PhD FACC FESC
Biomarkers in early atherosclerosis
Dimitris Tousoulis MD, PhD, FACC, FESC, Anna-Maria Kampoli, MD, George Latsios MD, Gerasimos Siasos MD, Christodoulos Stefanadis, MD, FACC, FESC
Biomarkers in essential hypertension
Emmanuel Androulakis MD, Dimitris Tousoulis MD PhD FACC FESC, Nikolaos Papageorgiou MD, Christodoulos Stefanadis MD PhD FESC FACC
Biomarkers in hyperlipidemia
Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD,George Latsios MD, Gerasimos Siasos MD, Evangelos Oiconomou MD, Christodoulos Stefanadis MD PhD FESC FACC
Cardiac biomarkers in acute coronary syndromes
Konstantinos Toutouzas MD, Andreas Synetos MD, Maria Drakopoulou MD, Dimitris Tousoulis MD, Christodoulos Stefanadis MD
Biomarkers in congestive heart failure
Chiara Andreoli, MD, John T. Parissis, MD
Biomarkers of Pulmonary Hypertension and Pulmonary Embolism
Helias Stamatopoulos MD, Stella Brili MD
Coronary artery by-pass grafting and biomarkers
Constantina Aggeli MD, Ioannis Felekos MD, Emanuel Poulidakis MD, Iosif Koutagiar MD, Erifili Venieri MD, Christodoulos Stefanadis MD, FACC, FESC
Biomarkers of peripheral arterial disease
Marietta Charakida MD, PhD, Dimitris Tousoulis MD, PhD
Biomarkers in cardiorenal syndrome
Costas Tsioufis MD, Themistoklis Katsimichas MD, Anastasios Milkas MD, Dimitris Tousoulis MD, PhD, FACC, FESC
Cardiac arrhythmias: is there a role for biomarkers?
Polychronis Dilaveris, MD, FESC, Konstantinos Gatzoulis, MD, Dimitris Tousoulis, MD, PhD, FESC, FACC, Christodoulos Stefanadis, MD, FESC, FACC
The role of biomarkers in the antiplatelet treatment
Gerasimos Siasos MD, MSc, PhD, Dimitris Tousoulis MD, PhD, FACC, Marina Zaromitidou MD, Evangelos Oikonomou MD, Christodoulos Stefanadis MD, PhD, FACC, FESC

Part II: Novel biomarkers

Novel biomarkers used in the assessment of acute coronary syndrome
Dimitris Tousoulis MD PhD FACC FESC, Emmanuel Androulakis MD MSc, Nikolaos Papageorgiou, MD, Christodoulos Stefanadis MD PhD FESC
Novel cardiac biomarkers and application to heart failure
Evangelos Oikonomou MD, Dimitris Tousoulis MD, PhD, FACC, Gerasimos Siasos MD, PhD, Nikolaos Papageorgiou MD, Christodoulos Stefanadis MD, PhD, FACC, FESC
The role of genetic traits in cardiovascular disease
Alexios S. Antonopoulos MD, Regent Lee MD, PhD, Dimitris Tousoulis MD, PhD, Charalambos Antoniades MD, PhD
MicroRNAs: a novel cardiac biomarker
Nikolaos Papageorgiou MD, Dimitris Tousoulis MD PhD FACC FESC, Anna Kontogeorgou MD, Emmanuel Androulakis MD, Christodoulos Stefanadis MD PhD FACC FESC